Senseonics Holdings, Inc. (SENS)
| Market Cap | 388.15M |
| Revenue (ttm) | 10.02M |
| Net Income (ttm) | -109.15M |
| Shares Out | 236.52M |
| EPS (ttm) | -0.51 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $1.58 |
| Previous Close | $1.20 |
| Change ($) | 0.38 |
| Change (%) | 31.67% |
| Day's Open | 1.84 |
| Day's Range | 1.50 - 2.04 |
| Day's Volume | 203,403,482 |
| 52-Week Range | 0.36 - 2.04 |
Senseonics Holdings (SENS) stock is on the rise Friday with heavy trading despite a lack of news concerning the pharmaceutical company. The post SENS Stock Alert: 10 Things to Know Before Inve...
Investors need to pay close attention to Senseonics Holdings (SENS) stock based on the movements in the options market lately.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable con...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...
This article is going to explain what penny stocks are and discuss four penny stocks under $1 to watch as small-cap stocks continue a hot streak this winter. First thing's first, what are penn...
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Senseonics Holdings (SENS) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Senseonics has had a large win via the Ascensia Diabetes collaboration structure, that creates shareholder value with long-tailed returns. The Eversense device will benefit from Ascensia's lar...
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q3 2020 Results - Earnings Call Transcript
Senseonics (SENS) delivered earnings and revenue surprises of -66.67% and -2.42%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable con...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable conti...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.
Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q2 2020 Results - Earnings Call Transcript
Senseonics (SENS) delivered earnings and revenue surprises of 100.00% and -76.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.
TOKYO and BASEL, Switzerland, Aug. 10, 2020 /PRNewswire/ -- PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Ho...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.
NEW YORK, Aug. 3, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciar...
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Senseonics Holdings (SENS) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q1 2020 Results - Earnings Call Transcript
Senseonics (SENS) delivered earnings and revenue surprises of -75.00% and -95.97%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Senseonics Holdings (SENS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q4 2019 Results - Earnings Call Transcript
Senseonics (SENS) delivered earnings and revenue surprises of -12.50% and 13.49%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
An overall market sell-off stemming from increased coronavirus worries weighed on all three healthcare stocks.
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The company presented data on its continuous glucose monitoring system, but investors may be more excited about being joined by George Soros.
Investors reacted enthusiastically to a positive coverage decision for the company's Eversense CGM device.
It wasn’t a good quarter for the diabetes-device company.
The continuous glucose monitoring systems maker's main problem: declining sales.
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q3 2019 Results - Earnings Call Transcript
Senseonics (SENS) delivered earnings and revenue surprises of 0.00% and -30.14%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Written by: Craig Adeyanju | FinScreener Penny stocks, on the surface, look attractive because they generally have prices under $5. However, many penny stocks belong in that category for a rea...
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q2 2019 Results - Earnings Call Transcript
Senseonics (SENS) delivered earnings and revenue surprises of -6.25% and 1.93%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Dilution is on the way, causing at least temporary pain for shareholders.
The continuous glucose system (CGM) maker posted solid revenue growth but missed Wall Street's revenue and earnings estimates.
Senseonics Holdings Inc. (SENS) CEO Tim Goodnow on Q1 2019 Results - Earnings Call Transcript
About SENS
Senseonics Holdings, a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
| Industry Diagnostics & Research | Founded 1996 |
| CEO Timothy Goodnow | Employees 191 |
| Stock Exchange NYSEAMERICAN | Ticker Symbol SENS |
Financial Performance
In 2019, SENS's revenue was $21.30 million, an increase of 12.63% compared to the previous year's $18.91 million. Losses were -$115.55 million, 23.0% more than in 2018.
Analyst Forecasts
The average 12-month stock price forecast for SENS is 0.88, which is a decrease of -44.30% from the latest price.